Ernexa Therapeutics Inc. SEC filings ERNAW
Ernexa Therapeutics Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Jun 3, 2010. Its latest annual report, Form ARS, was filed on May 11, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 30, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 15, 2026 | Oct 15, 2026 |
| 3 | Initial insider ownership | Sep 22, 2026 | Sep 14, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 16, 2026 | Sep 16, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 16, 2026 | Sep 14, 2026 |
| 4 | Insider transaction | Sep 1, 2026 | Aug 31, 2026 |
| 4 | Insider transaction | Sep 1, 2026 | Aug 31, 2026 |
| 4 | Insider transaction | Sep 1, 2026 | Aug 31, 2026 |
| 4 | Insider transaction | Sep 1, 2026 | Aug 31, 2026 |
| 4 | Insider transaction | Sep 1, 2026 | Aug 31, 2026 |
| 4 | Insider transaction | Sep 1, 2026 | Aug 31, 2026 |
| 3 | Initial insider ownership | Aug 27, 2026 | Aug 4, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 2, 2026 | Jul 2, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jul 2, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 26, 2026 | Jun 22, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 20, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 13, 2026 | — |
| ARS | Annual report to shareholders | May 11, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | May 11, 2026 | — |
| DEF 14A | Proxy statement | May 11, 2026 | May 11, 2026 |
| 10-Q | Quarterly report | May 11, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
May 4, 2026 | May 1, 2026 |
| DEF 14C | Information statement | Apr 13, 2026 | Apr 13, 2026 |
| PRE 14C | Filing | Apr 1, 2026 | Apr 1, 2026 |
| EFFECT | Filing | Mar 30, 2026 | — |
| CORRESP | Letter to the SEC | Mar 26, 2026 | — |
| S-3/A | Filing | Mar 24, 2026 | — |
| 8-K |
Current report
Listing notice
|
Mar 20, 2026 | Mar 18, 2026 |
| UPLOAD | Letter from the SEC | Mar 20, 2026 | — |
| S-3 | Shelf registration | Mar 16, 2026 | — |
| 10-K | Annual report | Mar 13, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 26, 2026 | Feb 26, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Feb 17, 2026 | — |
| 4 | Insider transaction | Feb 17, 2026 | Feb 10, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 11, 2026 | Feb 6, 2026 |
| 424B5 | Prospectus supplement | Feb 10, 2026 | — |
| EFFECT | Filing | Feb 5, 2026 | — |
| CERT | Filing | Feb 5, 2026 | — |
| 8-A12B | Filing | Feb 5, 2026 | — |
| S-1/A | Amended registration statement | Feb 5, 2026 | — |
| S-1/A | Amended registration statement | Feb 4, 2026 | — |
| CORRESP | Letter to the SEC | Feb 3, 2026 | — |
| CORRESP | Letter to the SEC | Feb 3, 2026 | — |
| S-1 | Registration statement | Feb 3, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Dec 19, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Dec 16, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 11, 2025 | Dec 11, 2025 |
| 10-Q | Quarterly report | Nov 7, 2025 | Sep 30, 2025 |
| DRS | Filing | Oct 23, 2025 | — |
| DRSLTR | Filing | Oct 22, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 18, 2025 | — |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 7, 2025 | Jun 21, 2025 |
| 8-K |
Current report
Auditor change
|
Jul 7, 2025 | Jun 30, 2025 |
| EFFECT | Filing | Jun 18, 2025 | — |
| 424B3 | Prospectus | Jun 18, 2025 | — |
| CORRESP | Letter to the SEC | Jun 16, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 16, 2025 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jun 12, 2025 | Jun 12, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jun 11, 2025 | — |
| 4 | Insider transaction | Jun 11, 2025 | Jun 9, 2025 |
| S-8 | Employee stock plan registration | Jun 11, 2025 | — |
| S-3 | Shelf registration | Jun 11, 2025 | — |
| 8-K |
Current report
Unregistered share sale, Other events
|
Jun 9, 2025 | Jun 9, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 2, 2025 | Jun 2, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 14, 2025 | — |
| 10-Q | Quarterly report | May 7, 2025 | Mar 31, 2025 |
| 4/A | Ownership document | May 7, 2025 | Sep 24, 2024 |
| EFFECT | Filing | Apr 29, 2025 | — |
| 424B3 | Prospectus | Apr 29, 2025 | — |
| CORRESP | Letter to the SEC | Apr 25, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 25, 2025 | — |
| S-3 | Shelf registration | Apr 16, 2025 | — |
| ARS | Annual report to shareholders | Apr 14, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 14, 2025 | Dec 31, 2024 |
| D | Filing | Apr 11, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Apr 4, 2025 | — |
| 4 | Insider transaction | Apr 4, 2025 | Apr 2, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 3, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Apr 3, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Mar 26, 2025 | Mar 26, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Mar 24, 2025 | Mar 20, 2025 |
| 10-K | Annual report | Mar 12, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Mar 12, 2025 | Mar 11, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Mar 5, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 8-K | Current report | Feb 13, 2025 | Feb 7, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2025 | — |
| 4 | Insider transaction | Feb 10, 2025 | Feb 7, 2025 |
| 4 | Insider transaction | Feb 10, 2025 | Feb 7, 2025 |
| 4 | Insider transaction | Feb 10, 2025 | Feb 7, 2025 |
| 4 | Insider transaction | Feb 10, 2025 | Feb 7, 2025 |
| 4 | Insider transaction | Feb 10, 2025 | Feb 7, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 28, 2025 | — |
| 4 | Insider transaction | Jan 14, 2025 | Jan 13, 2025 |
| 3 | Initial insider ownership | Jan 14, 2025 | Jan 7, 2025 |
| 8-K |
Current report
Listing notice, Officer or director change
|
Jan 10, 2025 | Jan 3, 2025 |
| 8-K |
Current report
Listing notice
|
Jan 3, 2025 | Dec 30, 2024 |
| 424B3 | Prospectus | Nov 18, 2024 | — |
| 424B3 | Prospectus | Nov 18, 2024 | — |
| 424B3 | Prospectus | Nov 18, 2024 | — |
| EFFECT | Filing | Nov 15, 2024 | — |
| D | Filing | Nov 14, 2024 | — |
| D | Filing | Nov 14, 2024 | — |
| CORRESP | Letter to the SEC | Nov 13, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 13, 2024 | — |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| S-1 | Registration statement | Nov 5, 2024 | — |
| 4 | Insider transaction | Nov 5, 2024 | Sep 23, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Shareholder vote results, Other events
|
Oct 29, 2024 | Oct 29, 2024 |
| ARS | Annual report to shareholders | Oct 16, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Oct 7, 2024 | Oct 7, 2024 |
| PRE 14A | Preliminary proxy statement | Sep 27, 2024 | Sep 27, 2024 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Sep 27, 2024 | Sep 24, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Sep 25, 2024 | Sep 24, 2024 |
| 8-K |
Current report
Listing notice
|
Sep 23, 2024 | Sep 17, 2024 |
| 8-K |
Current report
Other events
|
Aug 19, 2024 | Aug 16, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 4 | Insider transaction | Jun 25, 2024 | Jun 21, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 4 | Insider transaction | Apr 29, 2024 | Apr 26, 2024 |
| 4 | Insider transaction | Apr 29, 2024 | Apr 26, 2024 |
| 4 | Insider transaction | Apr 29, 2024 | Apr 26, 2024 |
| 8-K |
Current report
Listing notice
|
Mar 22, 2024 | Mar 19, 2024 |
| 10-K/A | Amended annual report | Mar 18, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 14, 2024 | Dec 31, 2023 |
| 3 | Initial insider ownership | Feb 16, 2024 | Feb 12, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 16, 2024 | Feb 12, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 31, 2024 | — |
| 424B3 | Prospectus | Jan 24, 2024 | — |
| EFFECT | Filing | Jan 22, 2024 | — |
| 8-K |
Current report
Listing notice
|
Jan 19, 2024 | Jan 17, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 19, 2024 | — |
| CORRESP | Letter to the SEC | Jan 18, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 17, 2024 | — |
| S-8 | Employee stock plan registration | Jan 16, 2024 | — |
| S-3 | Shelf registration | Jan 12, 2024 | — |
| 4 | Insider transaction | Jan 3, 2024 | Jan 1, 2024 |
| 4 | Insider transaction | Jan 3, 2024 | Jan 1, 2024 |
| 3 | Initial insider ownership | Jan 3, 2024 | Jan 1, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Dec 22, 2023 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Officer or director change, Other events
|
Dec 20, 2023 | Dec 14, 2023 |
| SC 13G | Ownership over 5% (passive) | Dec 20, 2023 | — |
| 4 | Insider transaction | Dec 20, 2023 | Dec 14, 2023 |
| D | Filing | Dec 20, 2023 | — |
| 4 | Insider transaction | Dec 18, 2023 | Dec 14, 2023 |
| 8-K |
Current report
Material agreement, New debt
|
Dec 14, 2023 | Dec 8, 2023 |
| 8-K |
Current report
Material agreement
|
Nov 16, 2023 | Nov 14, 2023 |
| 3 | Initial insider ownership | Nov 13, 2023 | Oct 30, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Officer or director change
|
Nov 1, 2023 | Oct 30, 2023 |
| 8-K |
Current report
Listing notice, Officer or director change, Other events
|
Oct 5, 2023 | Oct 3, 2023 |
| 8-K/A |
Amended current report
Officer or director change
|
Sep 26, 2023 | Aug 28, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Sep 8, 2023 | — |
| SC 13D/A | Amended ownership over 5% (active) | Sep 7, 2023 | — |
| 3 | Initial insider ownership | Sep 1, 2023 | Aug 28, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 31, 2023 | Aug 28, 2023 |
| SC 13G | Ownership over 5% (passive) | Aug 28, 2023 | — |
| 4 | Insider transaction | Aug 25, 2023 | Jul 13, 2023 |
| 424B3 | Prospectus | Aug 23, 2023 | — |
| EFFECT | Filing | Aug 22, 2023 | — |
| CORRESP | Letter to the SEC | Aug 18, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 17, 2023 | — |
| S-3 | Shelf registration | Aug 14, 2023 | — |
| 10-Q | Quarterly report | Aug 11, 2023 | Jun 30, 2023 |
| 4 | Insider transaction | Aug 10, 2023 | Aug 8, 2023 |
| 4 | Insider transaction | Aug 10, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Listing notice, Officer or director change
|
Aug 10, 2023 | Aug 4, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 2, 2023 | Aug 2, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Jul 26, 2023 | — |
| D | Filing | Jul 26, 2023 | — |
| D | Filing | Jul 26, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jul 21, 2023 | — |
| 4 | Insider transaction | Jul 18, 2023 | Jul 14, 2023 |
| 4 | Insider transaction | Jul 18, 2023 | Jul 14, 2023 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jul 18, 2023 | Jul 13, 2023 |
| 4 | Insider transaction | Jul 18, 2023 | Jul 14, 2023 |
| 8-K |
Current report
Material agreement
|
Jul 13, 2023 | Jul 12, 2023 |
| 3 | Initial insider ownership | Jul 11, 2023 | Jul 6, 2023 |
| 3 | Initial insider ownership | Jul 11, 2023 | Jul 6, 2023 |
| 8-K |
Current report
Officer or director change
|
Jul 11, 2023 | Jul 6, 2023 |
| 4 | Insider transaction | Jun 23, 2023 | Jun 21, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2023 | Jun 16, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| DEFA14A | Additional proxy material | May 10, 2023 | — |
| ARS | Annual report to shareholders | May 5, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | May 5, 2023 | — |
| DEF 14A | Proxy statement | May 5, 2023 | Jun 16, 2023 |
| 8-K |
Current report
Officer or director change
|
May 5, 2023 | May 2, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
May 2, 2023 | Apr 26, 2023 |
| 424B3 | Prospectus | Apr 25, 2023 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ERNA (Nasdaq), ERNAW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 748592
- Former names
- Eterna Therapeutics Inc. (until Apr 4, 2025); Brooklyn ImmunoTherapeutics, Inc. (until Oct 14, 2022); NTN BUZZTIME INC (until Mar 23, 2021); NTN COMMUNICATIONS INC (until Dec 20, 2005)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.